MARK4 Inhibited by AChE Inhibitors, Donepezil and Rivastigmine Tartrate: Insights into Alzheimer’s Disease Therapy

MARK4 Inhibited by AChE Inhibitors, Donepezil and Rivastigmine Tartrate: Insights into Alzheimer’s Disease Therapy

Microtubule affinity-regulating kinase (MARK4) plays a key role in Alzheimer’s disease (AD) development as its overexpression is directly linked to increased tau phosphorylation. MARK4 is a potential drug target of AD and is thus its structural features are employed in the development of new therape...

Full description

Bibliographic Details
Main Authors:	Anas Shamsi, Saleha Anwar, Taj Mohammad, Mohamed F. Alajmi, Afzal Hussain, Md. Tabish Rehman, Gulam Mustafa Hasan, Asimul Islam, Md. Imtaiyaz Hassan
Format:	Article
Language:	English
Published:	MDPI AG 2020-05-01
Series:	Biomolecules
Subjects:	acetylcholinesterase inhibitors drug design and discovery kinase inhibitors molecular modeling and docking isothermal titration calorimetry Alzheimer’s disease
Online Access:	https://www.mdpi.com/2218-273X/10/5/789

Similar Items

Mechanistic insights into MARK4 inhibition by galantamine toward therapeutic targeting of Alzheimer’s disease
by: Mohd Adnan, et al.
Published: (2023-09-01)

Unraveling Binding Mechanism of Alzheimer’s Drug Rivastigmine Tartrate with Human Transferrin: Molecular Docking and Multi-Spectroscopic Approach towards Neurodegenerative Diseases
by: Anas Shamsi, et al.
Published: (2019-09-01)

Comparison of the Binding of Reversible Inhibitors to Human Butyrylcholinesterase and Acetylcholinesterase: A Crystallographic, Kinetic and Calorimetric Study
by: Terrone L. Rosenberry, et al.
Published: (2017-11-01)

Unraveling the Binding Mechanism of Alzheimer’s Drugs with Irisin: Spectroscopic, Calorimetric, and Computational Approaches
by: Rashid Waseem, et al.
Published: (2022-05-01)

Multispectroscopic and Molecular Docking Insight into Elucidating the Interaction of Irisin with Rivastigmine Tartrate: A Combinational Therapy Approach to Fight Alzheimer’s Disease
by: Rashid Waseem, et al.
Published: (2021-03-01)

Multifunctional Donepezil Analogues as Cholinesterase and BACE1 Inhibitors
by: Keith D. Green, et al.
Published: (2018-12-01)

The Potential Effect of Insulin on AChE and Its Interactions with Rivastigmine In Vitro
by: Tahereh Jamshidnejad-Tosaramandani, et al.
Published: (2021-11-01)

The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease (review of Technology Appraisal No. 111): a systematic review and economic model
by: M Bond, et al.
Published: (2012-04-01)

Evaluation of the Adverse Effects of Chronic Exposure to Donepezil (An Acetylcholinesterase Inhibitor) in Adult Zebrafish by Behavioral and Biochemical Assessments
by: Gilbert Audira, et al.
Published: (2020-09-01)

Study of jack bean urease interaction with luteolin by the extended solvation model and docking simulation
by: Maryam Mazinani, et al.
Published: (2020-12-01)

Rationalizing the Role of Monosodium Glutamate in the Protein Aggregation Through Biophysical Approaches: Potential Impact on Neurodegeneration
by: Ishfaq Ahmad Ahanger, et al.
Published: (2021-03-01)

The protective role of tacrine and donepezil in the retina of acetylcholinesterase knockout mice
by: Yun-Min Yi, et al.
Published: (2015-10-01)

Synthesis of New Indole Derivatives Structurally Related to Donepezil and Their Biological Evaluation as Acetylcholinesterase Inhibitors
by: Samar I. Faggal, et al.
Published: (2012-04-01)

Postoperative Administration of the Acetylcholinesterase Inhibitor, Donepezil, Interferes with Bone Healing and Implant Osseointegration in a Rat Model
by: Faez Saleh Al-Hamed, et al.
Published: (2020-09-01)

Neuroprotection of Cholinergic Neurons with a Tau Aggregation Inhibitor and Rivastigmine in an Alzheimer’s-like Tauopathy Mouse Model
by: Maciej Zadrozny, et al.
Published: (2024-04-01)

Cognitive impairment and electroconvulsive therapy in geriatric depression, what could be the role of rivastigmine? A case series
by: Audrey Monica van Schaik, et al.
Published: (2015-09-01)

Evaluation of Activity of Sesquiterpene Lactones and Chicory Extracts as Acetylcholinesterase Inhibitors Assayed in Calorimetric and Docking Simulation Studies
by: Andrzej Jaśkiewicz, et al.
Published: (2022-09-01)

Use of donepezil for neurocognitive recovery after brain injury in adult and pediatric populations: a scoping review
by: Avery L Miller, et al.
Published: (2024-01-01)

Structural Refolding and Thermal Stability of Myoglobin in the Presence of Mixture of Crowders: Importance of Various Interactions for Protein Stabilization in Crowded Conditions
by: Zahoor Ahmad Parray, et al.
Published: (2021-05-01)

Acetylcholinesterase Inhibitors in the Treatment of Neurodegenerative Diseases and the Role of Acetylcholinesterase in their Pathogenesis
by: Łucja Justyna Walczak-Nowicka, et al.
Published: (2021-08-01)

Direct Oral FXa Inhibitors Binding to Human Serum Albumin: Spectroscopic, Calorimetric, and Computational Studies
by: Nory Mariño-Ocampo, et al.
Published: (2023-03-01)

Size-Dependent Interplay of Volume Exclusion Versus Soft Interactions: Cytochrome c in Macromolecular Crowded Environment
by: Zahoor Ahmad Parray, et al.
Published: (2022-05-01)

Clinical efficacy and safety of donepezil in the treatment of Alzheimer’s disease in Chinese patients
by: Zhang N, et al.
Published: (2018-10-01)

Synthesis, biological evaluation, and computational studies of N-benzyl pyridinium–curcumin derivatives as potent AChE inhibitors with antioxidant activity
by: Nafisah M. Al-Rifai, et al.
Published: (2023-12-01)

Interactions Under Crowding Milieu: Chemical-Induced Denaturation of Myoglobin is Determined by the Extent of Heme Dissociation on Interaction with Crowders
by: Khalida Nasreen, et al.
Published: (2020-03-01)

Preclinical Studies of Canagliflozin, a Sodium-Glucose Co-Transporter 2 Inhibitor, and Donepezil Combined Therapy in Alzheimer’s Disease
by: Gabriela Dumitrita Stanciu, et al.
Published: (2023-11-01)

Mechanistic Insight into the Enzymatic Inhibition of β-Amyrin against Mycobacterial Rv1636: In Silico and In Vitro Approaches
by: Md Amjad Beg, et al.
Published: (2022-08-01)

Characterization of hepatic enzyme activity in older adults with dementia: potential impact on personalizing pharmacotherapy
by: Campbell NL, et al.
Published: (2015-01-01)

Alzheimer disease and acetylcholinesterase inhibitors
by: Zahia Kabouche
Published: (2016-12-01)

Isoperibolic Titration Calorimetry as a Tool for the Prediction of Thermodynamic Properties of Cyclodextrins
by: Liliana Giraldo, et al.
Published: (2008-10-01)

A 24-Week, Randomized, Controlled Study to Evaluate the Tolerability, Safety and Efficacy of 2 Different Titration Schemes of the Rivastigmine Patch in Japanese Patients with Mild to Moderate Alzheimer's Disease
by: Yu Nakamura, et al.
Published: (2015-09-01)

Tertiary amine derivatives of chlorochalcone as acetylcholinesterase (AChE) and buthylcholinesterase (BuChE) inhibitors: the influence of chlorine, alkyl amine side chain and α,β-unsaturated ketone group
by: Xiao-hui Gao, et al.
Published: (2017-01-01)

“Click” assembly of novel dual inhibitors of AChE and MAO-B from pyridoxine derivatives for the treatment of Alzheimer’s disease
by: Jia Zhao, et al.
Published: (2022-02-01)

Structural Isomerism and Enhanced Lipophilicity of Pyrithione Ligands of Organoruthenium(II) Complexes Increase Inhibition on AChE and BuChE
by: Jerneja Kladnik, et al.
Published: (2020-08-01)

Natural acetylcholinesterase inhibitors: A multi-targeted therapeutic potential in Alzheimer's disease
by: Kumar Gajendra, et al.
Published: (2024-08-01)

Improving Anti-Neurodegenerative Benefits of Acetylcholinesterase Inhibitors in Alzheimer’s Disease: Are Irreversible Inhibitors the Future?
by: Donald E. Moss
Published: (2020-05-01)

Community Pharmacists’ Knowledge Regarding Donepezil Averse Effects and Self-Care Recommendations for Insomnia for Persons with AD
by: Marketa Marvanova, et al.
Published: (2017-07-01)

Clinical Recommendations for the Use of Donepezil 23 mg in Moderate-to-Severe Alzheimer's Disease in the Asia-Pacific Region
by: Marwan Sabbagh, et al.
Published: (2016-09-01)

QT interval prolongation and with donepezil, rivastigmine and galantamine
by: Katie Malone, et al.
Published: (2020-08-01)

Crystal structure correlations with the intrinsic thermodynamics of human carbonic anhydrase inhibitor binding
by: Alexey Smirnov, et al.
Published: (2018-02-01)